Sio Capital Management LLC 13D and 13G filings for Salarius Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-10 4:05 pm Sale | 2021-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Sio Capital Management LLC | 6,771 3.000% | -1,515 (-18.28%) | Filing |
2021-02-16 1:03 pm Purchase | 2020-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Sio Capital Management LLC | 8,286 8.350% | 8,286 (New Position) | Filing |